9TZ-16334-80712
1 vaccination
3 coded responses
3 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 201 / VA
- Registered
- 2022-11-16
- Relationship
- Child or adolescent in my care
- Guardian
- ZXR-30554-02963
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-11-02
Dose 1 — Moderna
-
2022-11-16
Registered in v-safe
-
2022-11-23
Survey response — day 21, dose 1, under 3MedDRA: Cough, Insomnia, Rhinorrhoea — Feeling: FairFree text: Cough and difficulty sleeping. Mild runny nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Survey response — day 28, dose 1, under 3MedDRA: Coxsackie viral infection, Hand-foot-and-mouth disease — Feeling: Good · Be unable to work or attend schoolFree text: (b)(6) had classic hand/foot/mouth from coxsackie virus.MedDRA releases: 2024-11 · check-in free text available
-
2023-05-05
Survey response — 6 months, dose 1, under 3MedDRA: Rhinorrhoea — Feeling: GoodMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-11-02 | Moderna | No |
Free text
Release 12 (Under 3) — day 21, dose 1, under 3
Symptoms: Cough and difficulty sleeping. Mild runny nose.
Release 12 (Under 3) — day 28, dose 1, under 3
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Coxsackie viral infection | · | · | ✓ |
| SD | Hand-foot-and-mouth disease | · | · | ✓ |
| SD | Insomnia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release